BOGLE INVESTMENT MANAGEMENT L P /DE/ - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$221,000
-88.3%
13,000
-90.4%
0.35%
+158.1%
Q3 2018$1,894,000
+274.3%
136,029
+325.4%
0.14%
+267.6%
Q2 2018$506,000
-58.8%
31,978
-55.3%
0.04%
-59.8%
Q1 2018$1,229,000
-93.0%
71,552
-78.5%
0.09%
-92.7%
Q3 2016$17,502,000
+28.9%
333,449
+1.6%
1.26%
+34.1%
Q2 2016$13,576,000
+392.2%
328,329
+393.9%
0.94%
+372.9%
Q4 2015$2,758,000
-29.5%
66,477
-61.2%
0.20%
-26.0%
Q1 2015$3,910,000
-20.0%
171,155
-5.5%
0.27%
-17.2%
Q4 2014$4,890,000181,1180.32%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,092,152$16,808,219,0009.64%
GREAT POINT PARTNERS LLC 1,226,785$18,880,0007.47%
Ghost Tree Capital, LLC 500,000$7,695,0003.46%
RTW INVESTMENTS, LP 713,954$10,988,0003.41%
ARMISTICE CAPITAL, LLC 506,000$7,787,0002.66%
EcoR1 Capital, LLC 149,000$2,293,0001.04%
Eventide Asset Management 1,164,900$17,928,0001.04%
Telemetry Investments, L.L.C. 102,500$1,577,0000.68%
J. Goldman & Co LP 313,527$4,825,0000.41%
AWM Investment Company, Inc. 118,199$1,819,0000.35%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders